Abstrakti
The role of mitochondria in immunity is increasingly recognized, but it is unclear how variation in mitochondrial DNA (mtDNA) contributes to variable infection outcomes. To quantify the effect of mtDNA variation on humoral and cell-mediated innate immune responses, we utilized a panel of fruit fly Drosophila melanogaster cytoplasmic hybrids (cybrids), where unique mtDNAs (mitotypes) were introgressed into a controlled isogenic nuclear background. We observed substantial heterogeneity in infection outcomes within the cybrid panel upon bacterial, viral and parasitoid infections, driven by the mitotype. One of the mitotypes, mtKSA2 protected against bacterial, parasitoid, and to a lesser extent, viral infections. Enhanced survival was not a result of improved bacterial clearance, suggesting mtKSA2 confers increased disease tolerance. Transcriptome sequencing showed that the mtKSA2 mitotype had an upregulation of genes related to mitochondrial respiration and phagocytosis in uninfected flies. Upon infection, mtKSA2 flies exhibited infection type and duration specific transcriptomic changes. Furthermore, uninfected mtKSA2 larvae showed immune activation of hemocytes (immune cells), increased hemocyte numbers and ROS production, and enhanced encapsulation response against parasitoid wasp eggs and larvae. Our results show that mtDNA variation acts as an immunomodulatory factor in both humoral and cell-mediated innate immunity and that specific mitotypes can provide broad protection against infections.
| Alkuperäiskieli | Englanti |
|---|---|
| Artikkeli | e1011476 |
| Julkaisu | PLoS Genetics |
| Vuosikerta | 20 |
| Numero | 11 |
| DOI - pysyväislinkit | |
| Tila | Julkaistu - 11 marrask. 2024 |
| OKM-julkaisutyyppi | A1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä |
Rahoitus
Financial support was provided by the Academy of Finland (322732, 328979 and 353367) and the Sigrid Jus\u00E9lius foundation (3122800849) grants to TSS, Tampere University Doctoral School funding and The Finnish Cultural Foundation grant to YB, and a Leverhulme Trust Research Project grant (RPG-2018-369) and a Branco Weiss Fellowship to PV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We thank Paulina Mika for helping with the Kallithea microinjections and Lauri Paulam\u00E4ki for assisting with processing the RNAseq data. The Drosophila work was carried out at the University of Edinburgh and at the Tampere University, at the Tampere Drosophila Facility which is partly funded by Biocenter Finland. Sequencing and initial bioinformatics analysis was carried out by Edinburgh Genomics, The University of Edinburgh. Funding:Financialsupportwasprovidedbythe AcademyofFinland(322732,328979and353367) andtheSigridJuse \u00B4 liusfoundation(3122800849) grantstoTSS,TampereUniversityDoctoralSchool fundingandTheFinnishCulturalFoundationgrant toYB,andaLeverhulmeTrustResearchProject grant(RPG-2018-369)andaBrancoWeiss FellowshiptoPV.Thefundershadnoroleinstudy design,datacollectionandanalysis,decisionto publish,orpreparationofthemanuscript.
| Rahoittajat | Rahoittajan numero |
|---|---|
| University of Edinburgh | |
| Branco Weiss Fellowship | |
| Suomen Kulttuurirahasto | |
| Biocenter Finland | |
| Research Council of Finland | 328979, 353367, 322732 |
| Research Council of Finland | |
| Leverhulme Trust | RPG-2018-369 |
| Leverhulme Trust | |
| Sigrid Juséliuksen Säätiö | 3122800849 |
| Sigrid Juséliuksen Säätiö |
YK:n kestävän kehityksen tavoitteet
Tämä tuotos edistää seuraavia kestävän kehityksen tavoitteita:
-
SDG 3 – Hyvä terveys ja hyvinvointi
Julkaisufoorumi-taso
- Jufo-taso 2
!!ASJC Scopus subject areas
- Ecology, Evolution, Behavior and Systematics
- Molecular Biology
- Genetics
- Genetics(clinical)
- Cancer Research
Sormenjälki
Sukella tutkimusaiheisiin 'A naturally occurring mitochondrial genome variant confers broad protection from infection in Drosophila'. Ne muodostavat yhdessä ainutlaatuisen sormenjäljen.Siteeraa tätä
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver